This Integrated Report presents a holistic view of Laurus' performance for FY 2025-26, bringing together financial and non-financial disclosures to explain how we create and sustain value over time.
Read MoreAdvancing Peptides development & manufacturing infrastructure in Vizag to support fully integrated programmes
Established Gene therapy / ADC process development lab in Hyderabad
Accelerating greenfield capacity creation for microbial fermentation in Vizag Completed

Guided by the principle “Chemistry for Better Living”, we are advancing science through differentiated capabilities that expand access, enable innovation and support better health outcomes across global markets.

Dear
Stakeholders,
As Laurus marks two
decades of its journey,
FY 2025-26 stands
as a year that reflects
both progress and
perspective.
Dr. K. Ravindranath
Non-Executive Chairman and
Independent Director

Dear
Stakeholders,
As we complete 20 years, I am pleased
to share that, guided by our purpose of
improving lives through our chemistry
expertise, we continued to address evolving
healthcare needs while building enduring
value for our stakeholders.
Dr. Satyanarayana Chava
Executive Director and
Chief Executive Officer
Investments continued across our facilities spanning CDMO, Affordable Medicines and FDF. These expansions are reinforcing our commitment to being a high-quality development and manufacturing partner at scale, including in advanced therapies.
As the business expands into more complex molecules and emerging therapeutic areas, our R&D efforts are focused on enabling scalable processes, strengthening platform technologies and accelerating the transition from development to commercialisation.
Quality is a foundational principle that shapes how we operate, how we scale and how we build long-term credibility with customers and regulators.
Read MoreOur digital strategy is focused on building a resilient, secure and scalable technology backbone, while progressively embedding digital tools across operations to enhance efficiency, strengthen compliance and enable data-driven decision-making across the organisation.
We are advancing our strategy through three focused pillars: Innovate, Excel and Expand — reflecting our commitment to strengthening scientific capabilities, execution discipline and scalable infrastructure.
We integrate Environmental, Social and Governance (ESG) principles into our core business strategy, enabling responsible growth and long-term value creation.
Our people have been central to our success. We remain focused on building an organisation where talent, learning, safety and well-being evolve alongside business growth, enabling our teams to contribute meaningfully in a high-performance and values-driven environment.
Read More